Shanghai MicroPort EP MedTech Co., Ltd. (MicroPort EP) was established in the Shanghai International Medical Zone on August 31, 2010. MicroPort EP has been focusing on the development, manufacturing, and marketing of minimally invasive medical devices for the treatment of cardiac arrhythmia disease. It has developed a family of advanced cardiac ablation catheters, diagnostic catheters, and 3D navigation systems. These products are used by hundreds of physicians at over 1200 hospitals across China and beyond. The company was listed on the STAR Market (Stock code: 688351) of the Shanghai Stock Exchange on August 31, 2022.